Sweden: Palette turns to OrbiMed for debt facility in wake of SVB collapse

Global life sciences company, Palette Life Sciences, has signed a debt financing facility for up to US$75m with healthcare investor, OrbiMed. The non-dilutive capital provides further financial flexibility to support global commercial and product development activities across its product portfolio, while a portion of the proceeds will go towards paying Palette’s outstanding balance under its…

You must be a HMI Subscriber to view this content.

Subscribe Now »